Skip to Content

TV 7426 (Montelukast sodium 10 mg (base))

Pill imprint TV 7426 has been identified as Montelukast sodium 10 mg (base).

Montelukast is used in the treatment of allergic rhinitis; asthma, maintenance; bronchospasm prophylaxis; copd; asthma and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Montelukast sodium 10 mg (base) TV 7426
Montelukast sodium 10 mg (base) TV 7426
Montelukast sodium 10 mg (base) TV 7426
Montelukast sodium
TV 7426
10 mg (base)
Prescription only
Drug Class:
Leukotriene modifiers
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC):
Inactive Ingredients:
hydroxypropyl cellulose (type h)
hypromellose 2910 (6 mPa.s)
ferric oxide red
ferric oxide yellow
lactose monohydrate
magnesium stearate
corn starch
sodium lauryl sulfate
sodium starch glycolate type A potato
titanium dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.